It has been shown in in vivo experiments that the activation of the RAS-RAF-MEK-ERK pathway in HCL patients is mediated by the expression of cyclin D1 and the ERK protein in hairy cells of the bone marrow (11, 17). Here, MAP2K7 is linked to hairy cell leukemia.